Protein Production Technology Podcast · FPG Media

Special Episode: Justin Kolbeck - Wildtype

·31 min·2 clips

Early customers included pregnant diners, immunocompromised people, and people who had avoided sushi for eight months.

Justin Kolbeck joins the podcast to talk about Wildtype's recent momentum. The company has secured the FDA's first-ever no-questions letter for cultivated seafood. It has also started serving sushi-grade salmon in restaurants. Justin explains why seafood was the first focus for Wildtype. He says the team wanted to aim its technology at a category with real impact because seafood is the most consumed animal protein by humans. The conversation looks at how that original vision has held up over time. It stays grounded in the practical questions that shaped the company from the beginning. The host asks why sushi-grade salmon made sense as the first product. Justin describes the early decision as a mix of scientific opportunity and market importance. He frames the work as a way to make a meaningful dent in a huge protein category. Sustainability comes up as a major thread. Justin says the strongest motivation is not abstract climate language but the desire to leave fish in the ocean for the next generation. He argues that current fishing levels are not biologically sustainable. The discussion treats that as a broadly shared concern rather than a partisan one. That framing keeps the conversation on resource limits and long-term supply. The host then turns to what early adopters are responding to. Justin says sustainability matters, but in a concrete way. The interview stays careful about adding more than the source supports, and it does not overstate any single driver. The conversation keeps circling back to consumer behavior as something still being learned. Justin notes that cultivated seafood and cultivated meat may not trigger the same reactions. He avoids making claims about meat because Wildtype has not launched cultivated meat products. That restraint makes the answer feel specific rather than sweeping. It also keeps the conversation honest about what the company can actually see. The episode briefly widens to the broader market. Justin notes that, as of when the episode was recorded, Wildtype and Val were the two companies selling cultivated products in restaurants. He suggests it would be interesting to compare how people react after trying cultivated quail and cultivated fish. The comparison points to different product experiences rather than a single consumer story. Justin says some companies are trying to create something entirely new at the table. Wildtype is trying to recreate the taste of raw salmon through a different production method. That distinction matters throughout the conversation. The product is familiar in form even if the process behind it is not. Scale and cost sit just under the surface of the whole discussion. The FDA milestone is presented as a de-risking moment. The restaurant launch is presented as proof that the product can reach diners. Justin suggests that these steps may open the door to partnerships with larger companies. Those relationships would help bring cultivated seafood to greater scale and lower cost. The interview does not pretend the hard work is done. Instead, it treats regulatory progress and commercial entry as necessary milestones on a longer path. The result is a steady, industry-facing look at how cultivated seafood is moving from concept to market.

As heard by us

A practical look at cultivated seafood moving from regulatory milestone to restaurant tables.

A practical conversation about cultivated seafood, anchored by Wildtype's FDA milestone and its restaurant debut with sushi-grade salmon. It keeps its focus on why seafood came first, with the company pointing to the category's scale, the aim of having fish for the next…

Read the full review in PlayNext →

Why you'd press play

You want the clearest read on cultivated salmon moving from the FDA's first-ever no-questions letter to restaurant plates.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Protein Production Technology Podcast